Phoenix Equity Partners
| Type | Limited partnership |
|---|---|
| Industry | Private equity |
| Founded | 2001 |
| Headquarters | London, United Kingdom |
| Key people | David Burns (Managing Partner), Kevin Keck (Managing Partner) |
| Products | private equity funds |
| Total assets | £900 million |
| Website | www.phoenix-equity.com |
Phoenix Equity Partners is a United Kingdom mid-market private equity firm. It specialises in partnering with founder-entrepreneurs and their teams to grow their businesses.[1] Phoenix typically invests £10–60 million of equity per partnership.[2]
History
[edit]Phoenix was co-founded in 2001 by Hugh Lenon, Sandy Muirhead, James Thomas, David Burns and Kevin Keck. [3] David Burns and Richard Daw were made Managing Partners in 2014.[4]
More recently, in September 2024, the firm launched its Flagship Fund and Growth Partnership Fund, raising over £600 million to pursue mid-market buyouts and growth investments across the UK and Europe. [5]
In 2025, Kevin Keck was appointed co-Managing Partner alongside David Burns, reflecting a leadership update at the firm. [6]
Recent transactions
[edit]Phoenix has been active across technology, healthcare, and mid-market buyouts, with a series of investments and fund launches that reflect its sector-focused strategy.
In August 2024, Phoenix backed Cybanetix, a UK-based cybersecurity provider specialising in managed detection and response for mid-market businesses. [7]
The following month, the firm closed a £200 million continuation vehicle for Nineteen Group and Envisage Dental, extending ownership to fund buy-and-build strategies and organic growth initiatives. [8]
In December 2024, Phoenix acquired a stake in London Gynaecology, a specialist women's health clinic group. [9] The deal provided capital to expand services and locations amid rising investor interest in women's health. [10]
In July 2025, Phoenix invested in FutureMeds, a clinical trial management services provider operating across Europe, supporting growth in patient recruitment and site capacity across its network. [11]
References
[edit]- ↑ "Phoenix Equity Partners". Private Equity List. Retrieved 21 October 2025.
- ↑ "Private Equity List | Phoenix Equity Partners". privateequitylist.com. Retrieved 10 October 2025.
- ↑ McCarthy, Sebastian. "Phoenix Equity Partners rejigs leadership team". www.penews.com. Retrieved 10 October 2025.
- ↑ "Phoenix Equity Partners appoints Burns and Daw as managing partners". Private Equity Wire. 3 July 2014. Retrieved 21 October 2025.
- ↑ Didymus, Mike (18 September 2024). "UK's Phoenix Equity raises over £600m across new fund pair". AltAssets Private Equity News. Retrieved 10 October 2025.
- ↑ McCarthy, Sebastian. "Phoenix Equity Partners rejigs leadership team". www.penews.com. Retrieved 10 October 2025.
- ↑ "Deal Wrap: Phoenix Equity funds Cybanetix; Banneker's Xytech merges with Fabric". S&P Global Market Intelligence. Archived from the original on 25 March 2025. Retrieved 10 October 2025.
- ↑ Joseph, Irien (18 September 2024). "Phoenix raises £200m continuation fund for Nineteen, Envisage Dental". PE Hub. Retrieved 10 October 2025.
- ↑ Murdoch, Adrian (18 December 2024). "Phoenix takes stake in London Gynaecology". Healthcare Today. Retrieved 10 October 2025.
- ↑ Rose, Sophie (1 July 2025). "PE invests in women's health: an 'exploding' market with untapped potential". PE Hub. Retrieved 10 October 2025.
- ↑ "Phoenix takes stake in clinical trial management service FutureMeds". Real Deals. Retrieved 10 October 2025.
External links
[edit]
 | This article about a private equity or venture capital firm based in the United Kingdom is a stub. You can help Wikipedia by adding missing information. |